DYSPORTT

DYSPORTT the newest Botulinum Toxin type A approved by the FDA in the United states.  It was developed in the United Kingdom in the early 1990s to treat a number of neurological and opthalmic conditions under the name of Dysport.  Later it became approved for relaxing facial muscles of the forehead, thereby reducing and smoothing away frown lines and wrinkles.

---

EVOLENCE®

What is EVOLENCE®?

EVOLENCE® dermal filler represents a breakthrough in treating the effects of aging by replacing the collagen you've lost with collagen that lasts. A truly novel dermal filler, EVOLENCE® can immediately improve and refresh your appearance by smoothing out and softening the appearance of unwanted facial wrinkles and folds, and restoring structure and facial contour in volume-depleted areas. The visible, natural-looking results are achieved immediately, with minimal-to-no downtime, so you can get right back to your daily activities. EVOLENCE® is the first and only collagen dermal filler to provide immediate results that last through 12 months, so you avoid the costly repeat treatments often associated with other fillers.

Why is collagen so important for achieving a refreshed, youthful appearance?

Collagen is nature's most fundamental and abundant building block. In fact, collagen makes up to 80% of the skin's dermis, providing structure, strength, and support. Collagen depletes naturally over time as we age, leading to a tired or aged appearance. This happens through the formation of new wrinkles and folds, and changes in facial contour and structure. The natural pace of collagen loss can be accelerated by such factors as sun exposure, genetics, hormonal changes, and smoking. By replacing lost collagen with an advanced collagen compound that lasts, EVOLENCE® dermal filler can help enhance and maintain the structure, volume, and naturally younger-looking appearance of your skin.

What make EVOLENCE® dermal filler different?

EVOLENCE® dermal filler is made of natural collagen, one of the most prevalent materials in your body. The advanced collagen in EVOLENCE® has been naturally cross-linked, so it mimics the 3-dimensional structure of your skin's own collagen. This allows it to integrate beautifully and support your skin's own existing collagen network by adding structure, strength, and volume for a natural look and feel that last.

The unique collagen of EVOLENCE®:

• Achieves immediate, natural-looking results, so you can walk out of the office looking beautifully refreshed
• Causes minimal-to-no swelling or bruising, so you can get right back to daily activities
• Last through 12 months so it is convenient and reduces costly repeat visits
• Does not require a skin pre-test, so you can get results in 1 visit

While introduced to the US in late 2008, EVOLENCE® has been used extensively in Canada, Europe, Israel and Asia for several years.

Where is EVOLENCE® used?

EVOLENCE® is recommended for the correction of moderate-to-deep facial wrinkles and folds, such as nasolabial folds, the ones that appear from your nose to the corners of your mouth ("smile lines").

Click Here to view EVOLENCE® Before & After Gallery.

---

Latisse

Now, you can grow longer, fuller darker lashes.

It's not an illusion. It's your own eyelashes - only better

Get ready for an innovation in lashes.
LATISSE® (bimatoprost ophthalmic solution) 0.03% is the first and only prescription treatment approved by the FDA for inadequate or not having enough eyelashes, growing them longer, fuller and darker.

LATISSE® works effectively.
LATISSE® makes lash growth possible because of its active ingredient: bimatoprost. Although the precise mechanism of action is not known, research suggests that the growth of eyelashes occurs by increasing the percent of hairs in, and the duration of, the anagen (or growth) phase. Lashes can grow longer, thicker and darker because bimatoprost can also prolong this growth phase.

Clinically proven results you can see over time.
LATISSE® is FDA approved and effective. It's a once-a-day treatment you apply topically to the base of your upper eyelashes. Patients in a clinical trial saw results in as few as 8 weeks with full results after 12 to 16 weeks.

It's an innovation backed by research.
While LATISSE® is a treatment for inadequate or not enough eyelashes, it was developed through years of research by Allergan, a pharmaceutical leader with over 60 years of expertise in prescription eye care products.

It's an innovation backed by research.
While LATISSE® is a treatment for inadequate or not enough eyelashes, it was developed through years of research by Allergan, a pharmaceutical leader with over 60 years of expertise in prescription eye care products.

Click Here to see before & after of Brook Shields and the Latisse Gallery.

How to Apply

A few steps can lead to great lashes
Like every routine, applying LATISSE® (bimatoprost ophthalmic solution) 0.03% is all about consistency and precision. Once you follow the basic guidelines, the results will come gradually over time. To see the full effect of your eyelash transformation, take a "before" picture before you start the treatment, and keep taking pictures every 4 weeks to chart your progress.

Step 1

Before Applying
Before applying LATISSE® each night, ensure your face is clean, makeup and contact lenses are removed, and any other facial care products have already been applied.

Step 2

Prepare the Applicator
Remove an applicator from its tray. Then, holding the sterile applicator horizontally, place one drop of LATISSE® solution on the area of the applicator closest to the tip but not on the tip.

Step 3

Apply to Skin using Applicator
Immediately draw the applicator carefully along the skin at the base of the upper eyelashes (where the eyelashes meet the skin) just as you would apply liquid eyeliner. This area should feel lightly moist without runoff.

Step 4

Blot Excess
Blot any excess solution beyond the eyelid with a tissue.

Step 5

Dispose of Applicator
Dispose of the applicator after one use. Repeat for opposite eyelid, using a new sterile applicator to help minimize any potential for contamination from one eyelid to another.